Drug Therapy of Alzheimer's Dementia - MP2
Presented by: Zaneta M. Pronsky, MS, RD, FADA and Dean Elbe BSc (Pharm), BCCP
This audio presentation begins with a brief discussion of geriatric pharmacology and Alzheimer's symptoms, diagnosis and progression. The pharmacology of cholinesterase inhibitors and memantine (Namenda) used to treat Alzheimer's is delineated. Drugs used to treat symptoms of dementia are then presented. Adverse reactions of each class is reviewed with emphasis on clinically significant food-medication and herbal/dietary supplement-medication interactions. Case studies offer practical applications and real life situations. Includes handouts.
Participants will:
1. Be able to identify four physiologic changes in the geriatric individual which may lead to change in drug disposition in the body
2. Be able to list 3 recommendations to improve the safety of drug therapy in the geriatric individual
3. Be able to describe the mechanism by which medications for the treatment of Alzheimer's dementia and improve symptoms in the dementia patient
4. Be able to identify one or more medications considered safer in the geriatric patient for the treatment of dementia associated depression, anxiety, and psychosis
5. Be able to apply nutrition/medication interaction information to specific patients, such as those presented in case studies
Course Hours: 2
Level II Learning Codes: 2100, 3070, 4190, 5030, 5040, 5100, 5300
Please choose single or unlimited participants in the box on the right when ordering. Unlimited participants means that as many participants as you would like may listen and receive CEUs.
To hear this program, simply click on the file link and listen. If you don't complete the seminar in one session, you may return anytime within the 45 days of purchase to finish the program.